Treatment of donor‐specific antibody‐mediated rejection after heart transplantation by IgM‐enriched human immunoglobulin

Antibody‐mediated graft rejection caused by donor‐specific antibodies (DSA‐MR) remains a serious problem after heart transplantation (HTx). IgM‐enriched human intravenous immunoglobulin (IGM‐IVIG) consists of 76% IgG, 12% IgM, and 12% IgA and provides a new multifactorial approach for DSA‐MR. Betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Immohr, Moritz Benjamin, Akhyari, Payam, Aubin, Hug, Westenfeld, Ralf, Mehdiani, Arash, Bruno, Raphael Romano, Sipahi, Nihat Firat, Erbel‐Khurtsidze, Sophiko, Reinecke, Petra, Tudorache, Igor, Lichtenberg, Artur, Boeken, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318410/
https://www.ncbi.nlm.nih.gov/pubmed/33969938
http://dx.doi.org/10.1002/ehf2.13409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318410/
https://www.ncbi.nlm.nih.gov/pubmed/33969938
http://dx.doi.org/10.1002/ehf2.13409

Ejemplares similares